Haier Biology started from the research and development, production and sales of bio-medical cryogenic storage equipment, which is a new species of Internet of Things technology ecology based on the transformation of the Internet of Things. 

Haier Biology took the lead in breaking foreign monopoly, independently developed and mastered the core technology of ultra-low temperature refrigeration, and became the world's only provider of biomedical cryogenic storage equipment covering the full temperature range of -196 ° C to 8 ° C. After nearly 20 years of development, the company is at the leading level in the research and development of core technologies such as cascade cryogenic refrigeration system design, multistage refrigeration mixed refrigerant preparation, efficient heat transfer technology and constant temperature control technology. Up to now, Haier Biomedicine and its subsidiaries have a total of 263 patents that have been approved and are in application, including 65 invention patents. Core R&D personnel of Haier Biomedicine led or participated in the drafting of 9 national and industry standards in the biomedical cryogenic storage industry, basically covering all biomedical cryogenic storage products, and participated in the drafting of international standards of the World Health Organization (WHO). Promote the normative development of the industry.